The national lowest price is not real 23 drugs are complained!

The lowest price in the country is not true, and 23 drugs have been complained On October 25, Zhejiang Pharmaceutical Machinery Purchase Center issued the notice on publishing the price complaint handling results of online products of centralized drug purchase in our province (the Seventh Batch in 2019), 23 drugs were complained due to price and other reasons in the implementation of the national minimum price linkage results According to the relevant regulations of Zhejiang centralized purchase, through the procedures of verification and publicity, it was decided to reduce the online transaction price of 20 products such as irbesartan tablets from now on, and suspend the online transaction qualification of 3 products that did not agree to the price reduction According to the data, Zhejiang has already had seven batches of drugs declared to be the lowest price in China this year However, this processing result is also a dynamic adjustment For the most serious suspension of trading qualification, once the product accepts the price reduction, it will resume the online trading On November 14, 2018, Zhejiang Pharmaceutical purchase platform issued the notice on filling in and linkage of the national minimum online transaction price of online trading products in Zhejiang Province in 2018 In the document, Zhejiang requires 1814 bidding pharmaceutical companies involved to complete the filling in and linkage of the national minimum online transaction price of online trading products before December 3 And make it clear that if the complaint is not filled in truthfully, the online transaction qualification of relevant products will be suspended after verification, publicity and other procedures In April 2019, Zhejiang issued a notice to link the national minimum price of low-cost drugs, and pointed out that if the enterprises did not truthfully declare the national minimum price and affected the supply price of Zhejiang Province, 10% of the national minimum price shall be reduced as the reference price limit, and the next reference price adjustment qualification of the product shall be suspended At present, it is the first choice for many provincial drug procurement platforms Since 2019, Beijing, Anhui, Shandong, Sichuan, Guangxi and other provinces and cities have launched this work successively Some provinces and cities will implement dynamic adjustment to shorten the linkage cycle The difference is that some provinces require enterprises to declare the lowest price of five provinces, and take the middle value as the online price of their own province Some provinces' linkage rules will set some conditions, such as Henan requires enterprises to independently fill in the current national lowest bid (online) price of each provincial drug centralized purchase platform (including Henan Province), except for Guangdong, Fujian and Chongqing For enterprises, direct demand for linkage with the national minimum price will cause trouble In fact, some prices are negotiated by both parties according to the purchase quantity If other provinces do not have the restriction of purchase quantity, the direct demand for linkage of this price will often cause enterprises to abandon the bid in some regions Enterprises want to guarantee the price, but many provinces, such as Zhejiang and Anhui, will use the medical insurance payment standard and other tools to gradually squeeze the false high ingredients in the drug price when they want to link the national minimum price The national linkage of drug prices will pull the price to achieve the balance among enterprise profits, medical insurance funds and patient tolerance.